Sales rise 45.12% to Rs 42.84 crore
Net profit of Jagsonpal Pharmaceuticals rose 229.03% to Rs 5.10 crore in the quarter ended March 2021 as against Rs 1.55 crore during the previous quarter ended March 2020. Sales rose 45.12% to Rs 42.84 crore in the quarter ended March 2021 as against Rs 29.52 crore during the previous quarter ended March 2020.For the full year,net profit rose 116.77% to Rs 17.06 crore in the year ended March 2021 as against Rs 7.87 crore during the previous year ended March 2020. Sales rose 18.53% to Rs 187.95 crore in the year ended March 2021 as against Rs 158.57 crore during the previous year ended March 2020.
ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales42.8429.52 45 187.95158.57 19 OPM %11.934.13 -10.155.37 - PBDT7.641.83 317 22.9610.54 118 PBT7.381.51 389 21.879.41 132 NP5.101.55 229 17.067.87 117
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
